ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

Sharfstein To Leave FDA

January 7, 2011

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003